Cointime

Nuclidium

company

About

Nuclidium’s vision is to address the unmet need to detect and stage cancer more accurately.

  • 1 - 10

Highlights

Total Funding Amount
Fr2.40M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
Fr2.40M
Industries
Health Care,Medical
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Nuclidium’s vision is to address the unmet need to detect and stage cancer more accurately so that treatment options for cancer patients and their long-term survival can be significantly improved.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Fr2.40M
Nuclidium has raised a total of Fr2.40M in funding over 2 rounds. Their latest funding was raised on Mar 29, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 29, 2022 Grant Fr2.40M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nuclidium is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท